The RNA component of human telomerase

Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5'-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG)n. Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.

[1]  V. Rotter,et al.  Spot-1, a novel NLS-binding protein that interacts with p53 through a domain encoded by p(CA)n repeats. , 1995, Oncogene.

[2]  M. Blasco,et al.  Functional characterization and developmental regulation of mouse telomerase RNA , 1995, Science.

[3]  C. Greider,et al.  Developmental and tissue-specific regulation of mouse telomerase and telomere length. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Keiko Hiyama,et al.  Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.

[5]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[6]  D. Gottschling,et al.  TLC1: template RNA component of Saccharomyces cerevisiae telomerase. , 1994, Science.

[7]  C B Harley,et al.  Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Roos,et al.  Telomerase activity in vivo in human malignant hematopoietic cells. , 1994, Oncogene.

[9]  M. Wang,et al.  Expression efficiency of the human thrombomodulin-encoding gene in various vector and host systems. , 1994, Gene.

[10]  H. Perez,et al.  Human formyl peptide receptor ligand binding domain(s). Studies using an improved mutagenesis/expression vector reveal a novel mechanism for the regulation of receptor occupancy. , 1994, The Journal of biological chemistry.

[11]  T. Cech,et al.  Telomerase RNAs of different ciliates have a common secondary structure and a permuted template. , 1994, Genes & development.

[12]  C. Harley,et al.  Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes , 1994, Journal of virology.

[13]  C. Harley,et al.  Telomerase activity in human ovarian carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Autexier,et al.  Functional reconstitution of wild-type and mutant Tetrahymena telomerase. , 1994, Genes & development.

[15]  S. Barber,et al.  Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells , 1994, Molecular and cellular biology.

[16]  H. Schwartz,et al.  Telomere reduction in giant cell tumor of bone and with aging. , 1993, Cancer genetics and cytogenetics.

[17]  C. Welter,et al.  Telomeric associations and loss of telomeric DNA repeats in renal tumors , 1993, Genes, chromosomes & cancer.

[18]  G. Yeh,et al.  Telomere reduction in endometrial adenocarcinoma. , 1992 .

[19]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Feng,et al.  An altered repertoire of fos/jun (AP-1) at the onset of replicative senescence. , 1992, Experimental cell research.

[21]  D. J. King,et al.  Significant telomere shortening in childhood leukemia. , 1992, Cancer genetics and cytogenetics.

[22]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[24]  A. Avilion,et al.  Tetrahymena telomerase RNA levels increase during macronuclear development. , 1992, Developmental genetics.

[25]  R. Miller,et al.  Gerontology as oncology. Research on aging as the key to the understanding of cancer , 1991, Cancer.

[26]  E. Blackburn,et al.  Developmentally programmed healing of chromosomes by telomerase in tetrahymena , 1991, Cell.

[27]  W. Filipowicz,et al.  Alteration of the RNA polymerase specificity of U3 snRNA genes during evolution and in vitro , 1991, Cell.

[28]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[29]  H. Cooke,et al.  In vivo loss of telomeric repeats with age in humans. , 1991, Mutation research.

[30]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[31]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[32]  E. Blackburn,et al.  In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs , 1990, Nature.

[33]  E. Blackburn,et al.  Functional evidence for an RNA template in telomerase. , 1990, Science.

[34]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[35]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[36]  E. Blackburn,et al.  A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis , 1989, Nature.

[37]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[38]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A M Olovnikov,et al.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.

[40]  B. Mcclintock.  The Behavior in Successive Nuclear Divisions of a Chromosome Broken at Meiosis. , 1939, Proceedings of the National Academy of Sciences of the United States of America.